HEALTH IN TECH INC

Insider Trading & Executive Data

HIT
NASDAQ
Technology
Software - Application

Start Free Trial

Get the full insider signal for HIT

22 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
22
0 in last 30 days
Buy / Sell (1Y)
19/3
Acquisitions / Dispositions
Unique Insiders (1Y)
11
Active in past year
Insider Positions
11
Current holdings
Position Status
11/0
Active / Exited
Institutional Holders
17
Latest quarter
Board Members
10

Compensation & Governance

Avg Total Compensation
$603247.83
Latest year: 2024
Executives Covered
3
Comp records available
Form 8-K Events (1Y)
6
Personnel Changes (1Y)
6
Bonus Plan Events (1Y)
1
Organization Changes (1Y)
2
Board Appointments (1Y)
1
Board Departures (1Y)
3

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$1.40
Market Cap
$80.2M
Volume
100
EPS
$0.01
Revenue
$8.5M
Employees
80
About HEALTH IN TECH INC

Company Overview

Health In Tech (HIT) is an insurance-technology marketplace that vertically integrates underwriting, program management and digital member services for self-funded employer health plans and stop‑loss insurance through three subsidiaries: Stone Mountain Risk (SMR), International Captive Exchange (ICE) and HI Card. The company completed an IPO in December 2024 and reported 2024 revenue of $19.49M (up 1.8% YoY) with 18,348 enrolled employees billed and approximately $172M of policies sold; Q2 2025 showed meaningful acceleration with quarter revenue of $9.31M and enrolled employees rising to 24,839. HIT’s competitive differentiators are its eDIYBS automated quoting SaaS (bindable multi‑plan proposals in ~2 minutes with ~80% automated binds), a large provider network via HI Card, and a marketplace distribution model reliant on brokers, TPAs and carriers. Key operational and regulatory dependencies include third‑party AI/data vendors, carrier partnerships, HIPAA/privacy and state insurance rules, plus seasonality from annual renewal cycles.

Executive Compensation Practices

As a recent IPO technology/software application company operating in insurtech, HIT’s compensation mix is likely equity‑heavy (stock options and RSUs) combined with modest cash salary and performance cash incentives; the 10‑Q notes rising stock‑based compensation tied to public‑company transition supports this. Company‑specific incentive levers will emphasize both software/SaaS metrics (revenue growth, AR days improvement, product adoption of eDIYBS) and insurance underwriting metrics (underwriting margins, loss rates, carrier take rates, enrolled employees and policies sold), with adjusted EBITDA and automation/AI milestones used as non‑GAAP performance targets. R&D and product milestones (eDIYBS releases, HI Card adoption, AI underwriting accuracy) and retention of broker/TPA/carrier relationships are likely built into long‑term incentive awards to align management with product commercialization and partner expansion. Given rising public‑company costs and capitalization/amortization of internal‑use software, compensation committees may also use adjusted profitability measures (Adjusted EBITDA) for bonus calibration while excluding non‑cash amortization.

Insider Trading Considerations

Insider trading patterns at HIT will be shaped by the December 2024 IPO timeline and typical lock‑up expirations—expect clustered insider sales or option exercises after lock‑up release and around RSU vesting schedules created during the IPO. Trading activity may cluster around seasonal renewal windows (Dec/Jan) and major commercial announcements (new carrier partnerships, AI underwriting pilots, large broker/TPA wins) because those events materially affect forward revenue mix and underwriting risk. Regulatory and reputational sensitivities (HIPAA, AI governance, state insurance enforcement and carrier reactions to model errors) create natural blackout periods and heightened disclosure risk; insiders should be monitored for 10b5‑1 plan filings and sales around earnings, major product launches, or material underwriting outcomes. Finally, equity‑based compensation vesting combined with modest cash liquidity for executives (despite improved cash post‑IPO) can create predictable selling pressure as awards vest, so correlate filings (Form 4s) with vesting schedules and lock‑up expirations.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for HEALTH IN TECH INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime